FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
08/06/2026
Back to search
Official data from USPTO
ADULARIA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ADULARIA
ST13
US500000079421452Class
1, 5, 9, 42, 44
Filing
79421452
Registration
8016985
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
23
Latest update
08/06/2026
Trademark type
Word
Nice classes
1, 5, 9, 42, 44
Filing date
01/30/2025
Registration date
11/11/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/11/2025
Last transaction
08/06/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
25
Owner location
Zürich, CH
Examiner
STANWOOD, STEPHEN D
Law office
M60
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Adularia AG
Recolony AG
Representatives
Andrew N. Spivak Mosaic Legal Group, PLLC
Technical classification
Nice Classes
Class 1Class 5Class 9Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicals for use in industry and science; biological preparations for use in industry and science
Class 5
Probiotic supplements; Pharmaceutical preparations for use in immunotherapy and immune-oncology and for treating inflammatory conditions; Medical preparations for use in immunotherapy and immune-oncology and for treating inflammatory conditions; Veterinary preparations for use in immunotherapy and immune-oncology and for treating inflammatory conditions
Class 9
Downloadable computer software featuring artificial intelligence for drug discoverysoftware for identifyingdesigningtesting potential drug candidates
Class 42
Scientific research in the fields of immunotherapyimmune-oncologytreatment of inflammatory conditions; Industrial research in the fields of immunotherapyimmune-oncologytreatment of inflammatory conditions; Industrial design; Quality control of goods and services; Drug discovery services; Design and development of computers and programs for computers
Class 44
Medical services; Veterinary services
Publications
History of USPTO decisions and trademark events.
23 publications found
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
05/31/2026
XXCR
GENERIC MADRID TRANSACTION CREATED
05/31/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/11/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/11/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
11/11/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/23/2025
PUBO
PUBLISHED FOR OPPOSITION
09/23/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/17/2025
RFNT
REFUSAL PROCESSED BY IB
09/05/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/26/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/25/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/25/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/25/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/18/2025
RFRR
REFUSAL PROCESSED BY MPU
08/18/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
07/11/2025
CNRT
NON-FINAL ACTION WRITTEN
07/10/2025
DOCK
ASSIGNED TO EXAMINER
07/10/2025
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
05/02/2025
MAFR
APPLICATION FILING RECEIPT MAILED
04/14/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/14/2025
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
04/10/2025
Continuous trademark protection
Get notified about every new filing that threatens ADULARIA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.